This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
HCA Healthcare and UnitedHealthcare reached agreements just hours before their contracts were scheduled to expire on Sunday, capping a monthslong dispute that threatened in-network access to 38 hospitals across four states. The country’s biggest hospital chain and its biggest insurer had been duking it out for months to no avail before they finalized terms on Saturday evening.
Alnylam Pharma has been riding high since revealing top-line results from its HELIOS-B trial of vutrisiran in transthyretin-mediated amyloidosis (ATTR) – but a look at the full data seems to have disappointed investors.Shares in the company retreated after the presentation of the results at the European Society of Cardiology (ESC) conference, which confirmed a 28% reduction in the primary endpoint of deaths from any cause and recurrent cardiovascular events after at least 33 months of follow-up.
Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a phase 3 study, potentially clearing the way for regulatory approval, although in two other studies, patients earlier in the disease failed to see a benefit. A top company executive said he believes that the positive result would help build confidence among investors in the company’s research and development efforts.
Akums Drugs and Pharmaceuticals has announced the appointment of Amrut Medhekar as the Chief Executive Officer of its CDMO business, effective August 24, 2024. Medhekar brings over 27 years of experience in the pharma industry. His expertise spans corporate strategy, business leadership, key account management, portfolio strategy and supply management.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Formally releasing the new Bioeconomy policy at the National Media Centre, Union Minister of State (I/C) Science and Technology, Dr Jitendra Singh hailed India as the global torchbearer of the next Industrial Revolution. “BioE3 policy will prove to be a milestone not only for the bio-economy but a game changer for Viksit Bharat @2047.” The Bio E3 policy was recently approved by the Union Cabinet chaired by Prime Minister Narendra Modi.
96
96
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Formally releasing the new Bioeconomy policy at the National Media Centre, Union Minister of State (I/C) Science and Technology, Dr Jitendra Singh hailed India as the global torchbearer of the next Industrial Revolution. “BioE3 policy will prove to be a milestone not only for the bio-economy but a game changer for Viksit Bharat @2047.” The Bio E3 policy was recently approved by the Union Cabinet chaired by Prime Minister Narendra Modi.
A 76-year-old male has a past medical history of hypertension, diarrhea, mild cognitive impairment, diabetes, osteoarthritis, and gout. He has had a concern that has been ongoing for about 3 months with the symptoms recently escalating over the last 1-2 weeks. “Diarrhea problems” is what the patient is reporting. His primary provider recently did a […] The post Diarrhea Problems – Case Study appeared first on Med Ed 101.
Making Sustainability Sustainable Click to download: September 2024 Digital Magazine The post Express Pharma September 2024 appeared first on Express Pharma.
The exhaled breath condensate mask was able to successfully monitor and accurately detect breath for nitrate in patients with asthma or chronic obstructive pulmonary disease.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
In this episode, I’ll discuss an article about the side effects of sugammadex vs neostigmine. Episode 953: Sugammadex Versus Neostigmine Side Effects Subscribe on iTunes , Android , or Stitcher Despite its relatively higher cost, sugammadex is a very popular reversal agent for neuromuscular blockade in the perioperative setting compared to the alternative of neostigmine.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Robert F. Kennedy Jr.’s priorities may seem like a random grab bag of contrarianism, conspiracies, and earnest environmental activism: vaccine skepticism , Bitcoin enthusiasm , government-run organic farming communes to wean people off pharmaceuticals , opposition to corporate polluters , embrace of climate change skeptics. But there is nothing random about these positions.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content